C4 Therapeutics, Inc. Shares Outstanding
C4 Therapeutics, Inc. (CCCC) had Shares Outstanding of 122.91 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-11
- 2026-06-30: Shares outstanding (split-adjusted) 122.91M shares; Shares authorized (split-adjusted) 300.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 104.04M shares; Shares authorized (split-adjusted) 300.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 96.91M shares; Shares authorized (split-adjusted) 300.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 74.17M shares; Shares authorized (split-adjusted) 300.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 122.91M shares 10-Q · filed 2026-08-11 | 300.00M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 104.04M shares 10-Q · filed 2026-05-12 | 300.00M shares 10-Q · filed 2026-05-12 |
| 2025-12-31 | 96.91M shares 10-Q · filed 2026-08-11 | 300.00M shares 10-Q · filed 2026-08-11 |
| 2025-09-30 | 74.17M shares 10-Q · filed 2025-11-06 | 300.00M shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 71.01M shares 10-Q · filed 2025-08-07 | 300.00M shares 10-Q · filed 2026-08-11 |
| 2025-03-31 | 70.99M shares 10-Q · filed 2025-05-07 | 150.00M shares 10-Q · filed 2025-05-07 |
| 2024-12-31 | 70.63M shares 10-K · filed 2026-02-26 | 150.00M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 70.56M shares 10-Q · filed 2024-10-31 | 150.00M shares 10-Q · filed 2024-10-31 |
| 2024-06-30 | 68.82M shares 10-Q · filed 2024-08-01 | 150.00M shares 10-Q · filed 2024-08-01 |
| 2024-03-31 | 68.78M shares 10-Q · filed 2024-05-08 | 150.00M shares 10-Q · filed 2024-05-08 |
| 2023-12-31 | 60.47M shares 10-K · filed 2025-02-27 | 150.00M shares 10-K · filed 2025-02-27 |
| 2023-09-30 | 49.26M shares 10-Q · filed 2023-11-01 | 150.00M shares 10-Q · filed 2023-11-01 |
| 2023-06-30 | 49.07M shares 10-Q · filed 2023-08-08 | 150.00M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 49.05M shares 10-Q · filed 2023-05-04 | 150.00M shares 10-Q · filed 2023-05-04 |
| 2022-12-31 | 48.97M shares 10-K · filed 2024-02-22 | 150.00M shares 10-K · filed 2024-02-22 |
| 2022-09-30 | 48.95M shares 10-Q · filed 2022-11-03 | 150.00M shares 10-Q · filed 2022-11-03 |
| 2022-06-30 | 48.88M shares 10-Q · filed 2022-08-04 | 150.00M shares 10-Q · filed 2022-08-04 |
| 2022-03-31 | 48.75M shares 10-Q · filed 2022-05-05 | 150.00M shares 10-Q · filed 2022-05-05 |
| 2021-12-31 | 48.69M shares 10-K · filed 2023-02-23 | 150.00M shares 10-K · filed 2023-02-23 |
| 2021-09-30 | 48.59M shares 10-Q · filed 2021-11-10 | 150.00M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 48.38M shares 10-Q · filed 2021-08-11 | 150.00M shares 10-Q · filed 2021-08-11 |
| 2021-03-31 | 43.11M shares 10-Q · filed 2021-05-13 | 150.00M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 43.06M shares 10-K · filed 2022-02-24 | 150.00M shares 10-K · filed 2022-02-24 |
| 2020-10-31 | (m) | 150.00M shares 10-K · filed 2024-02-22 |
| 2020-09-30 | 1.63M shares 10-Q · filed 2020-11-12 | 370.00M shares 10-Q · filed 2020-11-12 |
| 2019-12-31 | 1.43M shares 10-K · filed 2021-03-11 | 21.34M shares 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |